Revolution Medicines, Inc.
RVMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$600,093 | -$436,367 | -$248,705 | -$187,091 |
| Dep. & Amort. | $11,824 | $9,309 | $9,656 | $7,332 |
| Deferred Tax | -$762 | -$3,910 | -$419 | $0 |
| Stock-Based Comp. | $0 | $0 | $31,196 | $20,724 |
| Change in WC | $1,168 | $40,662 | -$13,489 | $8,724 |
| Other Non-Cash | $30,427 | $39,734 | -$2,640 | $3,131 |
| Operating Cash Flow | -$557,436 | -$350,572 | -$224,401 | -$147,180 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,308 | -$7,729 | -$10,816 | -$6,528 |
| Net Acquisitions | $0 | $0 | $13,300 | $135,589 |
| Inv. Purchases | -$2,136,623 | -$1,058,916 | -$612,769 | -$671,335 |
| Inv. Sales/Matur. | $1,592,537 | $724,047 | $599,469 | $535,746 |
| Other Inv. Act. | $0 | $0 | -$13,300 | -$135,589 |
| Investing Cash Flow | -$554,394 | -$342,598 | -$24,116 | -$142,117 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $959,129 | $392,392 | $298,045 | $291,241 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $284 | $836,808 | $3,387 | $2,938 |
| Financing Cash Flow | $959,413 | $1,229,200 | $301,432 | $294,179 |
| Forex Effect | -$667 | -$1,294 | $0 | $0 |
| Net Chg. in Cash | -$153,084 | $534,736 | $52,915 | $4,882 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $696,148 | $161,412 | $110,234 | $105,352 |
| End Cash | $543,064 | $696,148 | $163,149 | $110,234 |
| Free Cash Flow | -$567,744 | -$358,301 | -$235,217 | -$153,708 |